Close

Aclaris Therapeutics (ACRS) Announces Statistically Significant Data from A-101 Phase 2 as Common Warts Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA


Go back to Aclaris Therapeutics (ACRS) Announces Statistically Significant Data from A-101 Phase 2 as Common Warts Treatment
(NASDAQ: ACRS) Delayed: 1.22 --0 (-0%)
Previous Close $1.22    52 Week High $33.88 
Open $1.25    52 Week Low $14.12 
Day High $1.25    P/E N/A 
Day Low $1.22    EPS $0.00 
Volume 637,744